A randomized, controlled, phase 2 trial of nivolumab plus standard-dose or low-dose bevacizumab for recurrent glioblastoma (NAVAL)

被引：0
|
作者：
Ahluwalia, Manmeet Singh
Peereboom, David M.
Ozair, Ahmad
Khosla, Atulya Aman
Rauf, Yasmeen
Nayak, Lakshmi
Ciolfi, Marci
Alban, Tyler
Grabowski, Matthew
Rayman, Pat
Diaz, Marcella
Lathia, Justin
Lee, Eudocia Quant
Wen, Patrick Y.
Reardon, David A.
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] William Beaumont Univ Hosp, Dept Internal Med, Royal Oak, MI USA
[4] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Cleveland Clin Lerner Res Inst, Cleveland, OH USA
[7] Dana Farber Canc Inst, Div Neurooncol, Boston, MA 02115 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2072
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Low-dose versus standard-dose azithromycin for treatment of yaws
    Mikalova, Lenka
    Smajs, David
    [J]. LANCET GLOBAL HEALTH, 2018, 6 (04): : E357 - E358
  • [32] Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial
    Kamata, Ken
    Imai, Hajime
    Matsumoto, Hisakazu
    Yamashita, Yukitaka
    Kato, Takao
    Nishi, Katsuhisa
    Omoto, Shunsuke
    Minaga, Kosuke
    Yamao, Kentaro
    Hyodo, Tomoko
    Im, Sung-Woon
    Hara, Akane
    Yoshikawa, Tomoe
    Ishikawa, Rei
    Okamoto, Ayana
    Yamazaki, Tomohiro
    Nakai, Atsushi
    Ueshima, Kazuomi
    Chiba, Yasutaka
    Takenaka, Mamoru
    Watanabe, Tomohiro
    Kitano, Masayuki
    Kudo, Masatoshi
    [J]. JGH OPEN, 2023, 7 (09): : 659 - 666
  • [33] Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial
    Drew, David A.
    Schuck, Madeline M.
    Magicheva-Gupta, Marina, V
    Stewart, Kathleen O.
    Gilpin, Katherine K.
    Miller, Patrick
    Parziale, Melanie P.
    Pond, Emily N.
    Takacsi-Nagy, Oliver
    Zerjav, Dylan C.
    Chin, Samantha M.
    Krems, Jennifer Mackinnon
    Meixell, Dana
    Joshi, Amit D.
    Ma, Wenjie
    Colizzo, Francis P.
    Carolan, Peter J.
    Nishioka, Norman S.
    Staller, Kyle
    Richter, James M.
    Khalili, Hamed
    Gala, Manish K.
    Garber, John J.
    Chung, Daniel C.
    Yarze, Joseph C.
    Zukerberg, Lawrence
    Petrucci, Giovanna
    Rocca, Bianca
    Patrono, Carlo
    Milne, Ginger L.
    Wang, Molin
    Chan, Andrew T.
    [J]. CANCER PREVENTION RESEARCH, 2020, 13 (10) : 877 - 888
  • [34] Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial: An update.
    Haggag, Rasha Mohamed
    Farag, Kamel
    Abu-Taleb, Fouad
    Shamaa, Sameh
    Zekri, Abdel-Rahman
    ELBolkainy, Tarek
    Khaled, Hussein Mustafa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial-an update
    Haggag, Rasha
    Farag, Kamel
    Abu-Taleb, Fouad
    Shamaa, Sameh
    Zekri, Abdel-Rahman
    ELBolkainy, Tarek
    Khaled, Hussein
    [J]. MEDICAL ONCOLOGY, 2014, 31 (01)
  • [36] Low-dose bevacizumab plus weekly irinotecan in recurrent glioblastoma multiforme, after failure of temozolamide: A phase II study.
    El Ghazaly, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: A randomized, crossover comparison
    Toner, GC
    Shapiro, JD
    Laidlaw, CR
    Rischin, D
    Millward, MJ
    Wolf, M
    Januszewicz, H
    Mitchell, SV
    Curran, AC
    Matthews, JP
    Bishop, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3874 - 3879
  • [38] Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke The ENCHANTED Trial
    Zhou, Zien
    Delcourt, Candice
    Xia, Chao
    Yoshimura, Sohei
    Carcel, Cheryl
    Torii-Yoshimura, Takako
    You, Shoujiang
    Malavera, Alejandra
    Chen, Xiaoying
    Hackett, Maree L.
    Woodward, Mark
    Chalmers, John
    Xu, Jianrong
    Robinson, Thompson G.
    Parsons, Mark W.
    Demchuk, Andrew M.
    Lindley, Richard, I
    Mair, Grant
    Wardlaw, Joanna M.
    Anderson, Craig S.
    [J]. NEUROLOGY, 2021, 96 (11) : E1512 - E1526
  • [39] Low-dose ticagrelor yields similar antiplatelet efficacy as standard-dose ticagrelor in healthy Chinese subjects: an open-label, randomized, controlled trial
    Li Pan
    Ma Liping
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C131 - C131
  • [40] Pulse azathioprine and low-dose methotrexate vs. standard-dose methotrexate in treatment of patients with moderate-to-severe psoriasis: a randomized controlled trial
    El-Komy, Mohamed Hussein Medhat
    Sayed, Khadiga S.
    Gawish, Gehad
    Elaguizy, Menatallah Mohamed
    Azzazi, Yousra
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (09) : 1029 - 1035
12345